A case of progressive supranuclear palsy improved with tandospirone citrate

Clinical Neurology

Volumn 41, Issue 2-3, 2001, Pages 150-153

  Iijima, M ^a   Terashi, H ^a   Iwata, M ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

5 HT1A agonist; Progressive supranuclear palsy; Tandospirone citrate; Theraphy

Indexed keywords

LEVODOPA; SEROTONIN 1A AGONIST; TANDOSPIRONE;

AGED; ARTICLE; BRADYKINESIA; BRAIN ATROPHY; CASE REPORT; COGNITIVE DEFECT; DRUG EFFICACY; GAIT DISORDER; GAZE PARALYSIS; HUMAN; MALE; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE SUPRANUCLEAR PALSY; TREATMENT OUTCOME;

AGED; DRUG THERAPY, COMBINATION; HUMANS; LEVODOPA; MALE; PIPERAZINES; PYRIMIDINES; SEROTONIN AGONISTS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0034932162     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome)
2. 1A receptors in the rat brain
3. Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers
4. 3H]citalopram